XML 67 R49.htm IDEA: XBRL DOCUMENT v3.19.2
Segment and Geographic Information (Tables)
 12 Months Ended
Apr. 26, 2019
Segment Reporting [Abstract]  
Schedule of Net Sales by Reportable Segment
The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:
Net Sales
 
Fiscal Year
(in millions)
2019
 
2018
 
2017
Cardiac and Vascular Group
$
11,505

 
$
11,354

 
$
10,498

Minimally Invasive Therapies Group
8,478

 
8,716

 
9,919

Restorative Therapies Group
8,183

 
7,743

 
7,366

Diabetes Group
2,391

 
2,140

 
1,927

Total
$
30,557

 
$
29,953

 
$
29,710
Reconciliation of Income Before Provision for Income Taxes from Segments to Consolidated
Segment EBITA
 
Fiscal Year
(in millions)
2019
 
2018
 
2017
Cardiac and Vascular Group
$
4,541

 
$
4,460

 
$
4,134

Minimally Invasive Therapies Group
3,266

 
3,346

 
3,434

Restorative Therapies Group
3,323

 
3,058

 
2,868

Diabetes Group
739

 
634

 
690

Segment EBITA
11,869

 
11,498

 
11,126

Interest expense
(1,444
)
 
(1,146
)
 
(1,094
)
Interest income
283

 
397

 
366

Amortization of intangible assets
(1,764
)
 
(1,823
)
 
(1,980
)
Corporate
(1,253
)
 
(1,437
)
 
(1,232
)
Centralized distribution costs
(1,688
)
 
(1,936
)
 
(1,543
)
Restructuring and associated costs
(407
)
 
(107
)
 
(373
)
Acquisition-related items
(88
)
 
(132
)
 
(230
)
Certain litigation charges
(166
)
 
(61
)
 
(300
)
Gain/(loss) on minority investments
62

 
—

 
—

IPR&D charges
(58
)
 
(46
)
 
—

Exit of businesses
(149
)
 
—

 
—

Divestiture-related items
—

 
(115
)
 
—

Gain on sale of businesses
—

 
697

 
—

Contribution to Medtronic Foundation
—

 
(80
)
 
(100
)
Hurricane Maria
—

 
(34
)
 
—

Impact of inventory step-up
—

 
—

 
(38
)
Income before income taxes
$
5,197

 
$
5,675

 
$
4,602
Reconciliation of Assets and Depreciation Expense from Segments to Consolidated
Total Assets and Depreciation Expense
 
Total Assets
 
Depreciation Expense
(in millions)
April 26, 2019
 
April 27, 2018
 
2019
 
2018
 
2017
Cardiac and Vascular Group
$
15,453

 
$
15,407

 
$
194

 
$
183

 
$
180

Minimally Invasive Therapies Group
41,186

 
43,002

 
206

 
217

 
358

Restorative Therapies Group
16,825

 
15,245

 
217

 
146

 
167

Diabetes Group
3,095

 
2,900

 
34

 
29

 
29

Segments
76,559

 
76,554

 
651

 
575

 
734

Corporate
13,135

 
14,839

 
244

 
246

 
203

Total
$
89,694

 
$
91,393

 
$
895

 
$
821

 
$
937
Schedule of Net Sales to External Customers and Property, Plant, and Equipment, Net, by Geographical Region
The following table presents net sales for fiscal years 2019, 2018, and 2017, and property, plant, and equipment, net at April 26, 2019 and April 27, 2018 for the Company's country of domicile, countries with significant concentrations, and all other countries:
 
Net sales
 
Property, plant, and equipment, net
(in millions)
2019
 
2018
 
2017
 
April 26, 2019
 
April 27, 2018
Ireland
$
91

 
$
85

 
$
69

 
$
156

 
$
149

 
 
 
 
 
 
 
 
 
 
United States
16,194

 
15,875

 
16,663

 
3,122

 
2,927

Rest of world
14,272

 
13,993

 
12,978

 
1,397

 
1,528

Total other countries, excluding Ireland
30,466

 
29,868

 
29,641

 
4,519

 
4,455

Total
$
30,557

 
$
29,953

 
$
29,710

 
$
4,675

 
$
4,604